ESMO Preceptorship on Colorectal Cancer 2015

Oncology Meeting Resources

27 Mar - 28 Mar, Singapore

ESMO Preceptorship on Colorectal Cancer

The aims of this Preceptorship were to learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings; to understand the importance of pathology and histoprognostic factors; and to learn about the management of patients after progression, side effects of treatments, and in special situations.

On this page, you may download the PDF of presentations given at the ESMO Preceptorship on Colorectal Cancer 2015 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Search Meeting Resources by Keyword

Useful links

Presenter Presentation title Session title
D. Aust Early (and not so early) colorectal cancer: The pathologist’s point of view Early colorectal cancer
M. Saunders Perioperative radio/chemoradiotherapy for rectal cancer Early colorectal cancer
F. Seow-Choen The best method for distal rectal resection Early colorectal cancer
D. Aust Microsatellite instability and other molecular markers – how useful are they? Adjuvant settings of colorectal cancer
H.L. Kong Adjuvant treatment for colon cancer III Adjuvant settings of colorectal cancer
C.H. Köhne Adjuvant treatment of stage II: Which patients to treat? Adjuvant settings of colorectal cancer
J. Han Lim Stage II Transverse Colon cancer without high risk factor Clinical cases
P. Chansriwong Rectal cancer case Clinical cases
J.-Y. Douillard Review of the ESMO consensus conference on metastatic colorectal cancer Metastatic colorectal cancer, liver limited metastases
C.H. Köhne Development of conventional chemotherapy in mCRC, BSC vs, Chemo, biochemical modulation, oral fluoropyrimidines, development of combination chemotherapy Metastatic colorectal cancer, liver limited metastases
H. Lang Resection of liver limited metastasis (Resectable cases, Group 0) Metastatic colorectal cancer, liver limited metastases
C.H. Köhne Unresectable or borderline resectable (Group 1) chemotherapy +/- targeted agents Metastatic colorectal cancer, liver limited metastases
H. Lang Treatment of metastatic disease confined to the peritoneum Special clinical situations: Mono- or oligometastatic disease
H. Lang Strategy in CRC stage IV - The liver surgeon's view Special clinical situations: Mono- or oligometastatic disease
J.-Y. Douillard The role of EGFR inhibition in mCRC Metastatic colorectal cancer I